
|Articles|May 1, 2004
- Volume 0 0
Cream Restores Blood Flow to Feet
Advertisement
A recent study, the results of which were reported in Diabetes Care, found that Transdermal L-Arginine cream improved impaired blood flow in the feet of patients with diabetes. The cream enhanced circulation by 33% in the metatarsal region and by 35% at the Achilles tendon. Also, the cream increased temperature by 5?F at the metatarsal and by 8?F at the big toe.
L-Arginine is an amino acid that is the biochemical precursor of nitric oxide. Nitric oxide controls local blood flow by relaxing the smooth muscle lining of blood vessels.
Articles in this issue
over 22 years ago
Aging Brings Changesover 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinover 22 years ago
Can You Read These Rxs?over 22 years ago
Treatment of Sexually Transmitted Diseasesover 22 years ago
Pharmacist Misappropriates Trade Secretsover 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesover 22 years ago
HRT Is Linked to Breast Cancer Relapseover 22 years ago
Psoriasis May Be Treated Safely and Effectively with AdalimumabAdvertisement
Related to this article

Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.

Preserving patient access requires attention to the people, workflows, and financial structures behind the pharmacy counter, not just the number of open pharmacy locations.

The breakthrough is not only in cell and gene therapies but also in whether health care can translate them into practice.

Peer Reviewed
Semaglutide-Associated Sensory Skin Disturbance in Patients Without Diabetes Treated for Weight Loss
This case series describes 2 instances of cutaneous sensory disturbance during semaglutide therapy in patients without diabetes and discusses possible mechanisms as hypotheses requiring further investigation.

Pharmacists can help identify uncontrolled risk factors, review medications, and reinforce when patients should seek emergency care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
2
Dexmedetomidine Receives FDA Approval for Acute Treatment for Agitation Associated With Schizophrenia
3
FDA Approves Gefurulimab as First Once-Weekly, Self-Administered C5 Inhibitor for gMG
4
Semaglutide-Associated Sensory Skin Disturbance in Patients Without Diabetes Treated for Weight Loss
5



